Article
New strategies in acute myeloid leukemia: redefining prognostic markers to guide therapy.
Clinical cancer research : an official journal of the American Association for Cancer Research - 1 Oct 2012
Khan Irum, Altman Jessica K, Licht Jonathan D
Abstract excerpt
Although standard therapy for AML has been relatively constant over the past 2 decades, this may be changing with enhanced technologies allowing for the classification of acute myeloid leukemia (AML) into molecularly distinct subsets. Some specific subsets of AML have an excellent prognosis in re...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
